Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amy C Sherman

Showing results (1-10 of 59) with videos related to

Pageof 6
Sort By:
Current HIV/AIDS Reports|July 26, 2015
Extrahepatic manifestations of hepatitis C infection: navigating CHASMAmy C Sherman, Kenneth E Sherman
Expert Review of Vaccines|April 24, 2020
Serogroup A meningococcal conjugate vaccines: building sustainable and equitable vaccine strategiesAmy C Sherman, David S Stephens
NEJM Evidence|May 28, 2024
How To Measure Benefit in a Changing Pandemic - Olgotrelvir for SARS-CoV-2Amy C Sherman, Lindsey R Baden
The American Journal of the Medical Sciences|October 24, 2025
Update on InfluenzaAlisse Hannaford, Muneerah Aleissa, Amy C Sherman
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 18, 2022
Coronavirus Disease 2019 Vaccine Trials (and Tribulations): How to Improve the Process of Clinical Trials in a PandemicAmy C Sherman, Nadine Rouphael, Lindsey R Baden
Frontiers in Public Health|August 2, 2021
SARS-CoV-2 mRNA Vaccine Attitudes as Expressed in U.S. FDA Public Commentary: Need for a Public-Private Partnership in a Learning Immunization SystemElissa R Weitzman, Amy C Sherman, Ofer Levy
Clinics in Laboratory Medicine|February 14, 2022
Vaccine-Induced Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Response and the Path to Accelerating Development (Determining a Correlate of Protection)Amy C Sherman, Michaël Desjardins, Lindsey R Baden
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 17, 2022
Pediatric Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccines: Perceptions and Attitudes From the Food and Drug Administration Public CommentaryElissa R Weitzman, Amy C Sherman, Ofer Levy
JAMA|August 16, 2020
Influenza in the COVID-19 EraDaniel A Solomon, Amy C Sherman, Sanjat Kanjilal
Cold Spring Harbor Perspectives in Medicine|March 11, 2020
Systems Biological Analysis of Immune Response to Influenza VaccinationMario Cortese, Amy C Sherman, Nadine G Rouphael, et al.
Pageof 6

Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
Current HIV/AIDS Reports|July 26, 2015
Extrahepatic manifestations of hepatitis C infection: navigating CHASMAmy C Sherman, Kenneth E Sherman
Expert Review of Vaccines|April 24, 2020
Serogroup A meningococcal conjugate vaccines: building sustainable and equitable vaccine strategiesAmy C Sherman, David S Stephens
NEJM Evidence|May 28, 2024
How To Measure Benefit in a Changing Pandemic - Olgotrelvir for SARS-CoV-2Amy C Sherman, Lindsey R Baden
The American Journal of the Medical Sciences|October 24, 2025
Update on InfluenzaAlisse Hannaford, Muneerah Aleissa, Amy C Sherman
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 18, 2022
Coronavirus Disease 2019 Vaccine Trials (and Tribulations): How to Improve the Process of Clinical Trials in a PandemicAmy C Sherman, Nadine Rouphael, Lindsey R Baden
Frontiers in Public Health|August 2, 2021
SARS-CoV-2 mRNA Vaccine Attitudes as Expressed in U.S. FDA Public Commentary: Need for a Public-Private Partnership in a Learning Immunization SystemElissa R Weitzman, Amy C Sherman, Ofer Levy
Clinics in Laboratory Medicine|February 14, 2022
Vaccine-Induced Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Response and the Path to Accelerating Development (Determining a Correlate of Protection)Amy C Sherman, Michaël Desjardins, Lindsey R Baden
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 17, 2022
Pediatric Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccines: Perceptions and Attitudes From the Food and Drug Administration Public CommentaryElissa R Weitzman, Amy C Sherman, Ofer Levy
JAMA|August 16, 2020
Influenza in the COVID-19 EraDaniel A Solomon, Amy C Sherman, Sanjat Kanjilal
Cold Spring Harbor Perspectives in Medicine|March 11, 2020
Systems Biological Analysis of Immune Response to Influenza VaccinationMario Cortese, Amy C Sherman, Nadine G Rouphael, et al.
Pageof 6